Skip to main content

James Fickett, Kenneth Fasman, Daniel Masys, Stephan Burley

Premium

AstraZeneca of Waltham, Mass., has named James Fickett global director of bioinformatics. From 1980 to 1996 Fickett was a member of the “T-10” theoretical biology and biophysics group at Los Alamos National Laboratory, where he co-founded GenBank. He most recently served as director of bioinformatics research at GlaxoSmithKline.

Fickett will be based in Waltham and will oversee the company’s core bioinformatics groups in Boston, Wilmington, Del., and Alderley Park, UK. He reports to Kenneth Fasman, vice president and global head of R&D informatics.

 

Daniel Masys, associate clinical professor of medicine and director of biomedical informatics for the University of California, San Diego, School of Medicine, was elected an active member in the Institute of Medicine, part of the National Academy of Sciences.

Masys’ research interests include Internet-accessible medical records and health information, Internet utilities for conducting clinical research, and the analytical informatics of gene expression profiling using microarray technologies.

 

In January 2002, Stephan Burley will join San Diego-based Structural GenomiX as CSO and senior vice president of R&D.

Burley is the deputy for academic affairs at Rockefeller University, where he directs the Pels Family Center for Biochemistry and Structural Biology. He is a full investigator with the Howard Hughes Medical Institute and serves as the principal investigator of the New York Structural Genomics Research Consortium.

Burley was a co-founder of Prospect Genomics, a company acquired by SGX earlier this year, and was an original member of SGX’s scientific advisory board.

Filed under

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.